Full Text View
Tabular View
No Study Results Posted
Related Studies
Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)
This study is currently recruiting participants.
Verified February 2013 by University Hospital, Ghent
Study NCT01082393   Information provided by University Hospital, Ghent

First Received on February 26, 2010.   Last Updated on February 1, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Vitiligo
More general conditions related to this trial
Hypopigmentation
Pigmentation Disorders
Skin Diseases
Interventions listed in this trial
topical tacrolimus treatment
topical pimecrolimus treatment
local mometasone furoate treatment
cold cream
Additional drug interventions recognized in this trial
Mometasone furoate
Pimecrolimus
Tacrolimus
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Allergic Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Dermatologic Agents
Immunologic Factors
Immunosuppressive Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
University Hospital, Ghent


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services